Bacoderm

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bacoderm

Property Description
Active ingredient Mupirocin Calcium
Form Topical Cream or Ointment
Pharmacological class Antibacterial (Topical Anti-infective)
General purpose Suppress bacterial proliferation on the skin
Origin Semi-synthetic (derived from pseudomonic acid A)

Bacoderm is a prescription-only medication primarily used as a topical anti-infective to address bacterial presence on the skin. Containing the active component Mupirocin Calcium, it belongs to the distinct pharmacological class of antibacterial agents.


1. Bacoderm: Definition and Pharmaceutical Classification

Bacoderm is an antibacterial medicine applied externally to the skin, strictly requiring a prescription for its use. This medication is classified as a topical anti-infective because it is specifically formulated for dermal application, limiting its therapeutic action to the local area of concern. The active substance, Mupirocin, is chemically distinct from many common antibiotics and is an antibacterial agent. This establishes the drug’s role as a direct countermeasure against specific, susceptible bacteria.

2. Composition, Form, and Unique Origin

The primary active ingredient in Bacoderm is Mupirocin Calcium, a single-ingredient compound presented as a topical preparation. This medicine is available in two main dosage forms: an ointment or a cream. Mupirocin is considered a semi-synthetic substance because it is chemically derived from the natural product pseudomonic acid A, which is recognized for its short-chain fatty acid structure. The product is intended for topical application, ensuring focused delivery of the Mupirocin Calcium directly to the bacterial site.

3. General Therapeutic Purpose of Mupirocin

The general purpose of Mupirocin is to suppress the proliferation of susceptible bacteria on the skin surface to limit their ability to colonize or spread. As a specialized topical anti-infective, its high-level function is achieved by preventing these target organisms from producing the essential proteins they need to grow and multiply. This physiological action ensures the medication acts locally to manage the presence of bacterial colonization on the skin, which is the immediate therapeutic goal of using this localized treatment.

What side effects are possible with Bacoderm?

Possible Side Effects and Safety Information

The safety profile for Bacoderm (Mupirocin) is primarily characterized by localized reactions at the application site, as documented in government regulatory sources such as the FDA and EMA.


Officially Documented Adverse Reactions

The following effects are classified according to frequency in official regulatory labeling:

  • Common Reactions (Skin and Subcutaneous Tissue Disorders): Burning localized to the area of application.
  • Uncommon Reactions: Itching (Pruritus), Erythema (Redness), Stinging, Dryness, and local Cutaneous Sensitisation reactions.

Additional documented reactions reported in post-marketing or clinical trials include Headache, Nausea, Abdominal pain, Dizziness, and Rash.


Serious Adverse Reactions

Official labeling highlights the potential for serious, though rare, reactions, which fall under the Immune System and Gastrointestinal Disorders:

  • Systemic Allergic Reactions: Documented as Very Rare, these include severe responses such as Anaphylaxis, Urticaria, and Angioedema.
  • Clostridium difficile-Associated Diarrhea (CDAD): As with nearly all antibacterial agents, CDAD has been reported and may range in severity up to fatal colitis.

Safety Restrictions and Special Populations

Official warnings define specific safety constraints for use:

  • Renal Impairment Constraint: Mupirocin ointment should not be used in conditions where absorption of the polyethylene glycol base is possible, especially in individuals with moderate or severe renal impairment.
  • Administration Site Restriction: The medication should not be used on mucosal surfaces (e.g., inside the nose) or at intravenous cannulae or central intravenous sites.
  • Prolonged Use: Regulatory warnings state that prolonged use may result in the overgrowth of nonsusceptible microorganisms (including fungi).

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation on Mupirocin Calcium (Bacoderm) topical cream and ointment explicitly states there is no specific information regarding overdose of the product when applied to the skin. Since systemic absorption of the active component is minimal, acute overdose symptoms are not defined.

Official Regulatory Risk Factors and Actions

The highest priority for seeking urgent medical attention is tied to documented severe events, not acute topical overdose signs. The required actions are:

  • Immediate Medical Attention Required: Seek help for signs of a severe, life-threatening allergic reaction, such as swelling of the face, tongue, or lips, or wheezing and difficulty breathing. This is a mandated action for these systemic reactions.
  • Population-Specific Risk: Regulatory labeling advises caution for patients with moderate or severe renal impairment who are using the polyethylene glycol-based ointment over large areas of open wounds. This is due to the potential for excessive absorption of the excipient, which may pose a risk of renal toxicity.

No specific antidote for Mupirocin is known or documented in official regulatory labeling. In the event of a severe reaction or suspected overexposure, general management is limited to symptomatic and supportive treatment.

Therapeutic Uses of Bacoderm

What Bacoderm Treats: Main Uses and Benefits

Bacoderm (Mupirocin) is an antibacterial agent that may be part of symptomatic management for bacterial skin infections caused by susceptible pathogens, including Staphylococcus aureus and Streptococcus pyogenes.


Resolution of Superficial Bacterial Skin Infections

Bacoderm is applied across domains where additional symptomatic support is needed, primarily addressing conditions characterized by localized bacterial growth, such as Impetigo and minor traumatic lesions (cuts or scrapes) that have become secondarily infected. This topical anti-infective helps manage the infection and is relevant for easing symptoms that interfere with daily comfort. These manifestations include localized redness, swelling, and the discharge of fluid or crusting (exudate). This provides the patient benefit of contributing to improved comfort during periods of heightened symptoms.

“This medication is considered relevant in contexts involving inflammatory or irritative processes that are driven by specific superficial bacteria.”

Targeted Management of Bacterial Nasal Carriage

The active component may also be used in a different formulation and may be part of symptomatic management in clinical and institutional settings where the goal is to assist with managing risk related to bacterial colonization. This is relevant when supportive symptom management is appropriate for the presence of certain bacteria, particularly S. aureus, inside the nasal passages. This application contributes to lowering the patient’s overall risk of subsequent infection that may originate from colonization, supporting patients during episodes of heightened discomfort and contributing to easing the overall symptom load.


Quick Fact: Relief for Localized Skin Discomfort

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Bacoderm?

The eligibility for Bacoderm (Mupirocin Topical) is strictly defined by regulatory authorities based on a patient's medical status, age, and organ function.

Absolute Contraindications Bacoderm use is strictly contraindicated in any individual with a known history of hypersensitivity or allergy to the active substance, mupirocin, or any of the product’s excipients.

Age and Pediatric Eligibility Use is permitted in adults and certain pediatric groups. Safety and effectiveness are not established for the ointment in children younger than two months of age, or for the cream in children younger than three months of age, as documented in US labeling.

Condition and Organ Restrictions The ointment formulation is restricted for use in patients with moderate or severe renal impairment. This is due to the potential absorption of the polyethylene glycol base through damaged skin, which is excreted by the kidneys. The medicine is also not permitted for use on mucosal surfaces, such as the eyes or inside the nose.

Pregnancy and Lactation Status Use during pregnancy is conditional; it is recommended only if clearly needed. Caution must be exercised when the medicine is administered to a nursing mother.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Bacoderm (Mupirocin) confirms a limited potential for drug-drug interactions when applied topically, due to minimal systemic absorption of the active ingredient. Consequently, no specific drug-drug interaction statements are documented in the authoritative regulatory labeling.

However, several procedural and excipient-related constraints define the official interaction profile:


Procedural Constraints and Excipient Notes

Constraint Type Official Regulatory Statement
Mixing Restriction The product must not be mixed with other topical lotions, creams, or ointments, as this action may result in the dilution of the active drug concentration.
Population-Specific Caution Caution is mandated when using the ointment formulation in patients with moderate or severe renal impairment. This is due to the potential for systemic absorption of the polyethylene glycol excipient base, which could be relevant in individuals with compromised kidney function.
Absorption Condition The caution regarding the polyethylene glycol base extends to conditions where significant systemic absorption is possible, such as its application over large surface areas or to severe burns.

This official interaction structure highlights that the main constraints are logistical and condition-specific rather than pharmacological interactions with systemically administered medications. The regulatory profile is focused on avoiding dilution and managing the specific risk associated with the non-active ingredient in certain patient populations.

Mechanism of Action

The core mechanism of Mupirocin is a targeted interference with a fundamental life process in susceptible bacteria, resulting in the functional cessation of bacterial growth and replication.

Highly Selective Enzyme Inhibition

The mechanism centers on the competitive inhibition of the bacterial isoleucyl-tRNA synthetase (IleS). This enzyme is crucial for preparing the amino acid isoleucine to be incorporated into new proteins. By blocking its active site, the drug achieves selective toxicity. The binding maintains high specificity for the bacterial enzyme over the eukaryotic analog.

Cascade that Halts Protein Synthesis

Inhibition of IleS initiates a destructive cascade by depleting the cell of its charged isoleucyl-tRNA. This shortage immediately causes the cell's protein synthesis machinery (translation) to stall. The failure to produce essential proteins results in the functional collapse of the cell, which ultimately leads to the halting of bacterial replication in the localized environment.

Mechanistic Constraints: Resistance Pathways

The efficacy of this specific inhibitory mechanism is constrained by acquired bacterial resistance, primarily through the acquisition of the mupA gene. This gene provides a genetic bypass by encoding an alternate isoleucyl-tRNA synthetase that is unaffected by Mupirocin, allowing resistant bacteria to continue protein production and growth despite the drug's presence.

Dosage and Administration Information

How to Use Bacoderm: Official Administration Guidelines

Bacoderm (Mupirocin) is an antibacterial preparation whose use is defined by official administration protocols based strictly on topical application. The medicine is available as a 2% topical ointment or a 2% topical cream, and is approved exclusively for external use only on the skin surface, meaning it is not intended for ocular or nasal use.


Standard Dosage and Frequency

Instruction Entity Official Guideline
Route of Administration Topical application to the affected skin area.
Dosing Schedule A small amount of the product is applied to cover the entire lesion.
Frequency Application is standardized at three times daily ( TID) for both cream and ointment forms.
Course Duration The typical course of use is for 5 to 10 days.

Procedural and Age-Specific Use

Application should be performed by using a clean cotton swab or gauze pad to gently spread the medication over the affected skin area. The treated area may optionally be covered with a sterile gauze dressing. Concurrent use of Bacoderm with other topical lotions or ointments on the same application site should be avoided, as this may lead to dilution of the active component.

For pediatric patients, the administration frequency and dosing pattern are consistent with adult use. The cream formulation is approved for use in children 3 months of age and older, while the ointment is approved for those 2 months of age and older. If a scheduled application is missed, it should be applied as soon as the patient remembers, and the normal schedule resumed; no double dose should be used to compensate. Furthermore, if no clinical improvement is observed after 3 to 5 days of initiating use, the patient must be re-evaluated.

Recent Clinical Evidence

Research Focus and Initial Trials

Clinical research has explored the drug Bacoderm (Mupirocin) in the context of treating bacterial skin infections, such as impetigo and secondarily infected traumatic skin lesions (SITLs). Studies are focused on the drug's activity against certain bacteria, including Staphylococcus aureus (S. aureus) and Streptococcus pyogenes.

Efficacy and Comparative Studies

Randomized controlled trials (RCTs) have been conducted to evaluate the effects of topical Bacoderm (2% ointment or cream) on clinical and bacteriological outcomes. In studies comparing the topical ointment to vehicle (placebo) for impetigo, the active drug demonstrated an association with greater bacteriological success (elimination of the causative pathogen) and clinical improvement.

Comparative trials have also examined the topical ointment against oral antibiotics, such as erythromycin, in the treatment of impetigo. The clinical and bacteriological outcomes for Bacoderm ointment were reported to be non-inferior (not less effective) to those observed with the oral regimen. Similarly, in studies evaluating the topical cream for SITLs, outcomes were compared to those of oral cephalexin.

Safety and Long-Term Data

Adverse events reported in clinical trials were generally mild and confined to the application site. Common reactions included burning, stinging, itching, or pain. Systemic adverse reactions are rare, although cases of allergic reactions, including rash, urticaria, and angioedema, have been reported in post-marketing surveillance.

Patient Population Trial Focus
Children (age 3 months+) Safety and effectiveness established for cream in impetigo and SITLs
Adults Efficacy, safety, and comparisons with other treatments

Long-term data collection continues to monitor the drug's profile and potential for microbial resistance, which has been reported in surveillance studies following widespread use.

Frequently Asked Questions (FAQ)

Common questions about Bacoderm (FAQ)


Q: Is Bacoderm the same as Mupirocin or Neomycin?

Bacoderm is the brand name for the medicine that contains the active ingredient Mupirocin. Mupirocin is an antibacterial agent with a distinct chemical structure. Regulatory documents confirm that it is not chemically related to other common antibiotics, such as those in the Neomycin family.


Q: Does Bacoderm help with ingrown hairs or folliculitis?

While the primary US indications for Mupirocin are impetigo and infected skin lesions, regulatory leaflets in some countries do list the treatment of infected hair follicles, known as folliculitis, as an approved use. Information regarding specific approval should be reviewed by a healthcare professional.


Q: What does it mean that Bacoderm 'works locally'?

When a medicine works locally, it means its therapeutic action is focused only on the specific area where it is applied. Official information confirms that minimal amounts—less than 1%—of the active ingredient are typically absorbed through intact skin into the rest of the body, which is why it is used as a localized treatment.


Q: What are the signs of a serious side effect from Bacoderm?

Serious, though rare, side effects reported in official drug labels include symptoms of a severe allergic reaction, such as swelling of the face, tongue, or throat. Official labeling mentions that severe diarrhea potentially associated with Clostridium difficile has been reported in rare cases, as is possible with most antibacterial agents.


Q: Are there any herbal supplements that interact with Bacoderm?

Because Bacoderm has minimal absorption into the bloodstream, the potential for interaction with supplements or oral medicines is low. Official drug labels state that concurrent use with other products has not been studied. It is standard practice to review all medicines and supplements with a healthcare professional.


Q: Should Bacoderm be refrigerated or stored at room temperature?

Bacoderm should be stored at controlled room temperature, typically below 25 C (77 F). Official storage guidelines indicate the medicine should not be frozen to help maintain its stability.


Q: What is the recommended duration of treatment with Bacoderm?

The typical course of treatment for Bacoderm is 10 days. To help prevent the potential emergence of drug resistance or the overgrowth of other microorganisms, regulatory labels describe the typical treatment course as 10 days and caution against exceeding the prescribed duration.


Q: Why is Bacoderm sometimes used to prevent secondary infections?

In addition to treating active infections, some authoritative sources state that Mupirocin is sometimes used to prevent secondary infections in minor skin wounds. Due to its antibacterial action, its use can help manage the bacterial presence in minor burns, cuts, and other traumatic skin lesions.


Q: Does Bacoderm have any use for fungal or viral infections?

No, Bacoderm is an antibacterial agent and is effective only against specific types of susceptible bacteria. Official warnings indicate that it is inactive against most fungi and viruses, and prolonged use can actually lead to the overgrowth of non-susceptible organisms, including fungi.


Q: Is Bacoderm safe for elderly patients?

Studies to date have not identified any geriatric-specific problems that would limit the use of Mupirocin cream in elderly patients. However, regulatory caution is advised when the ointment formulation is used in any patient with moderate to severe kidney problems due to the absorption of an excipient (polyethylene glycol) used in the ointment base.


Q: Does Bacoderm contain parabens or preservatives?

Official information on inactive ingredients confirms that the cream formulation of Mupirocin contains benzyl alcohol and phenoxyethanol, which function as preservatives. The ointment formulation uses polyethylene glycol as its primary base excipient.


Q: Is there a known issue with Bacoderm causing sun sensitivity?

Sun sensitivity, or photosensitivity, is not listed as a common or serious adverse reaction in the official regulatory drug labels for Bacoderm.


Q: What is the main benefit of Bacoderm over other topical treatments?

The medicine has a unique mechanism of action, selectively targeting and inhibiting a critical bacterial enzyme (isoleucyl-tRNA synthetase). This unique mechanism means that Mupirocin typically does not share cross-resistance with other major classes of antibiotics.


Q: Does Bacoderm work against all types of bacterial skin infections?

No. Bacoderm is indicated only for infections caused by specific susceptible bacteria, most commonly certain strains of Staphylococcus aureus and Streptococcus pyogenes. It will not be effective against infections caused by non-susceptible bacteria or other microorganisms.


Q: How quickly should I expect to see improvement after using Bacoderm?

Official patient information suggests that if an impetigo infection has not improved within 3 to 5 days of starting treatment, a healthcare provider should be contacted. This guideline indicates that initial signs of improvement are generally expected to be noticeable within this timeframe.


Q: Can using Bacoderm for a long time lead to antibiotic resistance?

Yes. Official warnings state that as with other antibacterial products, prolonged or overuse of Bacoderm can contribute to the development of Mupirocin resistance and/or the overgrowth of other types of non-susceptible organisms.


Q: Can I apply makeup or sunscreen over Bacoderm?

Official information cautions against applying Bacoderm concurrently with any other topical products, such as lotions, creams, or ointments. Doing so may dilute the medication and reduce the concentration of the active ingredient, making it less effective.


Q: Does Bacoderm interact with oral antibiotics?

The potential for drug-drug interactions with oral (systemically administered) medications is considered very low because the active ingredient, Mupirocin, is only minimally absorbed into the bloodstream through the skin. However, the specific concurrent effects of other drugs have not been fully studied.


Q: Is Bacoderm safe to use during pregnancy?

There are no extensive studies on the use of Bacoderm in pregnant women. Official regulatory labels state that the drug should be used during pregnancy only if it is clearly needed and the potential benefit justifies the potential risk to the fetus.


Q: Why do some people need a culture test before being prescribed Bacoderm?

A culture test may be necessary because Bacoderm is indicated only for infections caused by susceptible isolates of certain bacteria. Testing helps ensure that the infection is caused by an organism the medicine can treat, especially since resistance to Mupirocin can develop.


Q: Is Bacoderm effective against MRSA (a specific type of bacteria)?

Mupirocin is known to be effective against certain strains of Staphylococcus aureus and is widely used for decolonization of Methicillin-Resistant S. aureus (MRSA) in the nose. However, its effectiveness is limited to susceptible isolates, and resistance has been reported.


Q: Why is Bacoderm sometimes called a 'topical' medication?

It is referred to as a topical medication because it is a preparation intended exclusively for use on the surface of the skin. This ensures the medicine is delivered directly to the infection site to work locally.


Q: Does using too much Bacoderm at once cause more side effects?

Patient information cautions against using more of the medication or applying it more often than directed. Using an excessive amount may increase the risk of unwanted side effects or cause skin irritation.


Q: Can I use Bacoderm if I have eczema or dermatitis?

Regulatory guidance advises caution when applying the ointment formulation to large areas of damaged skin, such as severe burns, particularly in patients with kidney impairment. This is due to the potential absorption of an ingredient in the ointment base. Specific guidance for common skin conditions like eczema is not explicitly defined in the official labeling and is best addressed by a healthcare professional.

How should Bacoderm be stored and disposed of?

️ How to Store and Dispose of Bacoderm?

Bacoderm (Mupirocin) must be stored strictly according to the conditions defined in the official regulatory labeling to ensure its stability and effectiveness.

Storage Requirement Official Condition
Temperature Store below 25 C (Controlled Room Temperature). Do not freeze.
Protection Keep in the original container, tightly closed, protected from heat and moisture. Do not store in a bathroom.
Child Safety Keep this medicine out of the sight and reach of children to prevent accidental ingestion or misuse.
In-Use Stability For Bacoderm Nasal Ointment, discard any remaining product 10 days after first opening the tube.

For disposal, do not dispose of Bacoderm via household waste or wastewater. Any unused, expired, or damaged medicine must be collected and returned to a pharmacist or pharmaceutical return program to ensure safe and environmentally sound disposal in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bacoderm found in:

A-Z Index: